[EN] SUBSTITUTED PIPERAZINES, (1,4) DIASZEPINES, AND 2,5-DIAZABICYCLO (2.2.1) HEPTANES AS HISTAMINE H1 AND/OR H3 ANTAGONISTS OR HISTAMINE H3 REVERSE ANTAGONISTS<br/>[FR] PIPERAZINES, (1,4) DIAZEPINES, ET 2,5-DIAZABICYCLO (2.2.1) HEPTANES SUBSTITUES EN TANT QU'ANTAGONISTES DE L'HISTAMINE H1 ET/OU H3 OU ANTAGONISTES INVERSES DE L'HISTAMINE H3
申请人:GLAXO GROUP LTD
公开号:WO2004035556A1
公开(公告)日:2004-04-29
The present invention relates to novel piperazine and azepine derivatives having pharmacological activity, processes for their preparation, to compositions containing them and to their use in the treatment of neurodegenerative disorders including Alzheimer's disease.
[EN] GLUCAGON ANTAGONISTS/INVERSE AGONISTS<br/>[FR] ANTAGONISTES/AGONISTES INVERSES DU GLUCAGON
申请人:NOVO NORDISK AS
公开号:WO1999001423A1
公开(公告)日:1999-01-14
Non-peptide compounds comprising a central hydrazide motif and methods for the synthesis thereof. The compounds act to antagonize the action of the glucagon peptide hormone.
非肽化合物包含一个中心肼基结构,并且其合成方法。这些化合物作用是拮抗胰高血糖素肽激素的作用。
Relation between Resonance Stabilized Chelate Rings and Acidity
作者:Richard T. Arnold、Joseph. Sprung
DOI:10.1021/ja01878a064
日期:1939.9
ANDREEVA, I. M.;BABESHKO, O. M.;BONDARENKO, E. M.;MEDYANTSEVA, E. A.;MINK+, ZH. ORGAN. XIMII, 1983, 19, N 10, 2146-2151
作者:ANDREEVA, I. M.、BABESHKO, O. M.、BONDARENKO, E. M.、MEDYANTSEVA, E. A.、MINK+